Significant improvements have been developed to tackle the challenges in viral vector manufacturing at each stage.
Greg Swan
Advertisement
Greg Swan is business development manager for Cell & Gene Therapy at Avantor.
Articles by Greg Swan
Advertisement
Latest Updated Articles
Addressing Developmental Challenges of Gene Therapy Viral VectorsPublished: October 16th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
5
